summary answer: Women at extremes of uterine length (,7.0 or .9.0 cm) were less likely to achieve live birth and women with uterine lengths ,6.0 cm were also more likely to experience spontaneous abortion.
Introduction
Anatomic and functional abnormalities of the uterus are associated with adverse fertility outcomes. These include uterine anomalies (Ozgur et al., 2007; Mollo et al., 2009) , cavity distortions affected by submucosal or large (.4 cm) intramural fibroids (Farhi et al., 1995; Jun et al., 2001; Somigliana et al., 2011) and defects of the endometrium (Revel, 2012) . In women without uterine abnormalities, little is known about what uterine factors, including uterine length, are predictive of fertility outcomes. Defining the relationship between fertility outcomes and pre-cycle uterine length would assist in counseling and management of women undergoing assisted reproduction technology (ART) treatments.
Studies of the relationship between uterine length and fertility outcomes in both the ART and general population are few. In the ART population, a prospective study by Egbase and colleagues found that women with a short (,7.0 cm) uterine length experienced a higher rate of ectopic pregnancy (Egbase et al., 2000) . In the general population, crosssectional studies paint an incomplete picture: while parous women have a longer average uterine length than nulliparous women (Platt et al., 1990; Esmaelzadeh et al., 2004; Canteiro et al., 2010; Langer et al., 2012) , uterine involution studies in parous women fail to demonstrate a paritydependent difference outside the puerperal period (de Castro, 1988; Negishi et al., 1999; Olayemi et al., 2002) . The question remains whether uterine length is associated with fertility potential. Routine pre-IVF cycle uterine length measurements allow for the use of prospectively gathered data to assess uterine length and IVF outcomes.
We hypothesize that uterine length is not associated with the incidence of chemical pregnancy, clinical pregnancy, spontaneous abortion and live birth in women with normal uterine anatomy undergoing IVF.
Methods

Study population
All women presenting to the Center for Infertility and Reproductive Surgery at Brigham and Women's Hospital, Boston, MA, for pre-IVF uterine length measurement between 2001 and 2011 were screened for inclusion in this retrospective cohort study. All women ages 21 -45 years old presenting for a uterine length measurement prior to fresh embryo transfer were eligible for inclusion. Exclusion criteria included women with uterine anomalies (unicornuate, bicornuate, septate uterus) and those with potentially altered anatomy due to history of diethylstilbestrol exposure, peritoneal chemotherapy or radiation and uterine perforation or rupture. Gestational carrier cycles and egg donor cycles were excluded and cycles not resulting in fresh embryo transfer were excluded to standardize time between uterine length measurement and IVF outcome. Women with balanced translocations and Turner's mosaics were excluded due to concern for a higher spontaneous abortion rate in this population. The protocol was approved by the Partners Human Research Committees. HIPAA waiver of authorization was accepted in place of written informed consent.
Out of concern for influence on cycle outcome, women with abnormal uterine physiology and those at higher risk for recurrent pregnancy loss were identified and only included after demonstrating homogeneity. Women considered as potentially having abnormal uterine physiology included women with any fibroids, those with clinically significant (defined as submucosal or large intramural) fibroids and women with adenomyosis as documented in the cycle-specific fertility treatment record. A 'concern for recurrent spontaneous abortion (RSAB) category' was developed to represent women in whom a preexisting diagnosis may systematically impact cycle outcomes and included women with a positive RSAB workup (prothrombin, antithrombin, homocysteine or Factor V Leiden mutations, Protein C or S deficiencies, anti-cardiolipin antibodies, lupus anticoagulant), women with a history of hypothyroidism and women with Asherman's syndrome (Ford and Schust, 2009 ).
Data collection
Information on infertility diagnoses, cycle-specific uterine length and cycle outcomes was abstracted from two clinical databases. Missing information was obtained by individual query of online medical records. A woman was considered as having a specific infertility diagnosis if it was one of the cyclespecific, provider-recorded infertility diagnoses. Providers included attending physicians, fellows and nurses.
Uterine Length measurement
Uterine sounding was performed in the proliferative phase (Days 5 -12) of the cycle antecedent to IVF treatment. It is practice in our clinic for embryo transfer to be performed within 1 month of uterine assessment. Uterine length measurements were performed according to standard procedure at our clinic (Schoolcraft et al., 2001; Coroleu et al., 2002) . After placement in the dorsal lithotomy position, speculum examination permitted visualization of the cervix. Blood or mucous surrounding the os was removed with cotton swabs. The outer sheath of the Rocket Duo catheter (Rocket Medical plc, Hingham, USA) was inserted through the cervix for measurement of uterine length, defined as the distance from the external cervical os to the uterine fundus (Rocket Medical plc 09/09/2011). For statistical analysis, cycles were grouped by initial uterine length: ,6.0 cm (very short, n ¼ 76), 6.0-6.9 cm (short, n ¼ 2014), 7.0 -7.9 cm (referent, n ¼ 4984), 8.0 -8.9 cm (long, n ¼ 1664), and ≥9 cm (very long, n ¼ 243).
Outcome measures
Chemical pregnancy was defined as cycles resulting in serum hCG ≥1 but without subsequent development of a gestational sac. Clinical pregnancy denoted cycles resulting in ultrasound confirmation of an intrauterine gestational sac but not fetal cardiac activity and/or followed by the passage of pathology-confirmed fetal tissue prior to the development of fetal cardiac activity. Spontaneous abortion was defined as cycles ending in the passage of pathology-confirmed fetal tissue or loss after documented fetal cardiac activity. Live birth denoted cycles resulting in live birth.
Statistical analyses
Analyses were performed using Statistical Analysis Software 9.2 (SAS Institute Inc., Cary, NC, USA). Continuous variables were presented as mean (+SD) or median (quartile 1 -quartile 3). Spearmen rank correlations and simple linear regression models were used to identify potential confounders, which were further evaluated in multivariate-adjusted linear regression models. Multivariate log binomial regression was used to evaluate cycle outcomes in the first cycle analysis. Generalized estimating equations, applying a binomial distribution, log link and compound symmetry covariance structure, were used to compare cycle outcomes in the instance of multiple cycles per woman. All models are adjusted for age, fibroids, assisted hatching (AH) and intracytoplasmic sperm injection (ICSI). Graphs were produced using cubic regression splines with knots specified at uterine length cut points of 6.0, 7.0, 8.0 and 9.0 cm. Statistical significance was assumed for P , 0.05.
To neither bias toward nor against those who achieved success in early cycles, all cycles were included in the primary analysis, which specifically accounted for the likelihood of treatment cessation based on outcome and the correlation between cycles in one woman . To address potential heterogeneity between subjects whereby women with more than one cycle may experience suboptimal outcomes, additional analyses restricting to one cycle per woman and further restricting to first-ever cycles were performed.
Results
The final cohort included 8981 cycles from 5120 adult women. The majority of patients were Caucasian (85.4%) with a mean age of 36.7 + 4.0 years and mean BMI of 25.7 + 6.4 kg/m 2 . Age, infertility diagnoses and stimulation protocols were similarly distributed across exposure groups while mean BMI, mean height and prevalence of fibroids and AfricanAmerican ethnicity increased across exposure groups (Table I) .
Distribution of uterine length in the IVF population
Median uterine length at the time of pre-cycle uterine measurement was 7.00 cm (7.00-7.75) with a mean of 7.24 cm (+0.71) and range of 5.00-12.00 cm. The majority (55.5%) of patients had uterine lengths between 7.00 and 7.99 cm, while about a fourth (23.3%) had uterine lengths ,7.00 cm and about a fifth (21.2%) had lengths ≥8.00 cm (Fig. 1) 
Comparison of IVF outcomes
When compared with women with uterine lengths of 7.00 -7.99 cm (referent), women with very short (,6.00 cm) uterine lengths were half as likely to experience live birth (RR: 0.53, 95% CI: 0.35 -0.81) and women with short (6.00-6.99 cm) uterine lengths were also less likely (RR: 0.91, 95% CI: 0.85 -0.98). Women with very long (.9.0 cm) uterine lengths were less likely to experience live birth, though not significantly less likely when compared with the referent group (Table II) . Women with short uterine lengths (,6.00 cm) were also more likely to experience spontaneous abortion compared with the referent group (RR: 2.16, 95% CI: 1.23 -3.78). When assessing firstever cycles only, women with uterine lengths ,6.00 cm experienced a higher likelihood of chemical pregnancy (Table II) . Results remained consistent when assessing one cycle per woman (n ¼ 5120) and when excluding women with a uterine factor diagnosis (n ¼ 8823).
Cubic regression spline models a significant inverse U-shaped association between uterine length and predicted probability of live birth whereby women with uterine lengths ,7.00 cm or .9.00 cm had a lower predicted probability of live birth while women with a uterine length of 8.00 cm experienced the highest predicted probability of live birth (Fig. 2) .
Assessment of covariates: BMI, fibroids and ethnicity
In a multivariate model adjusting for age, ethnicity and fibroids, obese (BMI ≥30 kg/m 2 ) women had a longer average uterine length than normal weight (BMI 20-24.9 kg/m 2 ) women (7.65 cm + 0.06 and 7.29 cm + 0.05, respectively, P , 0.001). When including adjustment for height, uterine length increased across increasing quartiles of weight (Q1, ≤56.8 kg: 7.19 cm (referent); Q2, 57.3-63.6 kg: 7.32 cm, P ¼ 0.008; Q3, 64.1-75.5 kg: 7.36 cm, P , 0.001; Q4, .75.5 kg: 7.62 cm, P , 0.001) and increasing percentiles of weight (10th percentile, ,52.3 kg: 7.13 cm, P , 0.001; 10-90th percentile, 52.3 -93.6 kg: 7.38 cm (referent); 90th percentile, .93.6 kg: 7.77 cm, P , 0.001). In all multivariate-adjusted models, women with fibroids had a longer average uterine length than women without fibroids (7.45 cm + 0.07 and 7.28 cm + 0.04, respectively, P ¼ 0.02). Ethnicity and height were not significantly associated with uterine length after adjusting for fibroids and weight.
Discussion
The major findings of this investigation demonstrate that women at extremes of uterine length (,7.00 cm and .9.00 cm) were less likely to achieve live birth after IVF. Compared with the referent group (precycle uterine lengths of 7.00-7.99 cm), women with short lengths (,7.00 cm) were less likely to achieve live birth and those with very short lengths (,6.00 cm) were more likely to experience spontaneous abortion. BMI, weight and fibroids were positively associated with uterine length. Although significant cubic regression spline demonstrated that women with very long (.9.00 cm) uterine length experienced a lower likelihood of live birth, this difference was not significant when compared with the referent group. This could be related to our designation of women with the most common pre-cycle uterine length (7.00-7.99 cm) as referent. The regression spline demonstrates that the uterine length conferring the highest probability of live birth is closer to 8.0 cm (7.75-8.25 cm) which might have been a more appropriate referent group. Our designation of a referent group with a suboptimal likelihood of live birth might have biased results toward the null.
Potential underlying mechanisms for a lower likelihood of live birth in women at extremes of uterine length are multiple and include anatomical and hormonal explanations. Though women with perceptible uterine anomalies were excluded, extremes of uterine length may signify anatomical variations that contribute a decreased likelihood of implantation. An anatomical argument is supported by prospective data showing women with uterine lengths ,7.0 cm experience higher rates of ectopic pregnancy (Egbase et al., 2000) . Research documenting a positive association between uterine size and estrone concentration (Chua et al., 1991; Ciobanu et al., 2003; Dandolu et al., 2010) implies extremes of uterine length might represent estrone deficiency or excess that adversely impacts cycle success (e.g. local or systemic aberrations in hormonal signaling might contribute to dysynchronous maturation of the endometrium). In women with very long uterine lengths, it is also possible a large uterus serves as an intermediate in the pathway between obesity and reduced cycle success (Shah et al., 2011) .
The finding that women with uterine lengths ,6.00 cm experienced a higher likelihood of chemical pregnancy when assessing initial but not all cycles may denote inadequate uterine receptivity in women with a small uterus that is overcome with different, prolonged or simply repeated uterine preparation, though a small sample size in this exposure group obscures substantive discussion.
The association of BMI and weight with uterine length is consistent with the hyperestrogenic environment of obesity in which estrone acts as a growth factor (Chua et al., 1991; Ciobanu et al., 2003; Dandolu et al., 2010) . In the present work, incremental increase in average uterine length across increasing percentiles of weight suggests that weight is associated with uterine length in a dose-dependent fashion (7.13 cm (10th percentile of BMI), 7.19 cm (25th percentile), 7.62 cm (75th percentile) and 7.77 cm (90th percentile)).
The association of fibroids and uterine length is consistent with cavity distortion from submucosal or large (≥4 cm) intramural fibroids (Jun et al., 2001; Oliveira et al., 2004) . Although infertile women with cavitydistorting fibroids are typically treated prior to IVF, it is possible our Figure 1 . Distribution of pre-cycle uterine length measured by uterine sounding in 8981 IVF cycles at a university-affiliated hospital.
Uterine length and IVF outcomes cohort includes women who did not receive pre-IVF myomectomy for reasons such as advanced maternal age. Notwithstanding, the statistical difference between a mean uterine length of 7.45 cm in women with fibroids and 7.28 cm in women without fibroids is unlikely to be clinically significant. Further, effect estimates were appreciably unchanged by adjustment for fibroids such that fibroids did not confound the association of uterine length and fertility outcomes in our models.
This study is the first to evaluate the association of pre-IVF cycle uterine length with live birth. In 2000, Egbase and colleagues conducted a prospective study comparing rates of implantation, clinical pregnancy and ectopic pregnancy by pre-IVF uterine length among 807 women and found that women with uterine lengths ,7 cm were more likely to experience ectopic pregnancy compared with women with uterine lengths of 7-9 cm (14.9 and 1.8%, respectively, P,0.001) and, though not significantly different, rates of clinical pregnancy were highest (46.5%) in women with uterine lengths of 7-9 cm compared with those in women with lengths ,7 cm (36.7%) or .9 cm (32.9%) (Egbase et al., 2000) . Their findings are in keeping with ours, though we compared more narrow exposure categories, assessed incidence of live birth and did not specifically evaluate ectopic pregnancy incidence.
Strengths of this investigation include a clinic population-based study population, isolation of women with anatomically normal uteri and assessment of live birth incidence. A sample size of 8981 cycles powered comparison of multiple IVF outcomes across five categories of uterine length and permitted more resolute assessment than prior studies.
Access to complete records allowed for assessment of the impact of fibroids, ethnicity and BMI on the relationship between uterine length and IVF outcomes. Variability in measurement was minimized by use of an identical catheter for all measurements and a standardized measurement technique.
The crude nature of uterine sounding limits our results. Though uterine sounding is a clinically relevant measurement that allows for results with practical implications, 3D saline infusion sonohysterography would provide optimal assessment of uterine measurements (Wachsberg et al., 1994) . Inter-observer variability from the recording of measurements by multiple providers may have introduced bias. Although the measurement technique is standardized, provider-specific differences in technique may impact our findings, as they have been shown to impact outcomes after embryo transfer (Hearns-Stokes et al., 2000) . The catheter used for uterine sounding is low resolution with 1 cm markings that require estimation of in-between lengths. Additionally, uterine length (from external os to uterine fundus) is a nonspecific measure composed of endometrial length (from internal os to uterine fundus) and cervical length (from internal to external os). If the ratio of these components varies as a function of uterine length, this could conceivably cause confounding, particularly given the well-studied association between a short cervix and adverse pregnancy outcomes (Berghella et al., 2011; Owen and Mancuso, 2012 potential as a confounder of uterine length and fertility outcomes (Shah et al., 2011) . Results are limited by incomplete information on gravidity and parity at the time of pre-cycle uterine length measurement. Across a 12-year study period, gravidity and parity were not reliably recorded in the query-able clinical databases, and individual medical record review for some 8000 cycles was impractical. The study population, while representative of the demographic composition at our clinic, was predominantly Caucasian such that results may not be generalizable to IVF clinic populations with other ethnic compositions. In summary, this study demonstrates that women with short uterine lengths have lower live birth rates and higher rates of spontaneous abortion. Median uterine length in our IVF population is 7.00 cm (7.00-7.75) and is positively associated with BMI and fibroids. Women at extremes of uterine length experience lower likelihood of live birth after IVF such that women with the highest probability of live birth have a pre-cycle uterine length between 7.00 and 9.00 cm. Reproducibility of results would solidify findings and inform patient counseling in women undergoing IVF. Uterine length and IVF outcomes
